PA Patient Safety Authority Examines Unsafe Injection Practices

[Guest guest]

http://www.infectioncontroltoday.com/news/2011/06/pa-patient-safety-authority-ex\

amines-unsafe-injection-practices.aspx

PA Patient Safety Authority Examines Unsafe Injection Practices

Posted in News, Bloodborne Pathogens, PPE & Standard Precautions, Sharps Safety,

Infections, Patient/Worker Safety, Patient Safety Print The June issue of the

Pennsylvania Patient Safety Authority Advisory includes a look at the occurrence

of bloodborne disease transmission related to unsafe injection practices.

Lapses in basic safe injection practices and infection control expose patients

to needless risk of transmission of bloodborne pathogens. The Centers for

Disease Control and Prevention and U.S. public health officials identified 51

reports of outbreaks of hepatitis B virus and hepatitis C virus infection

primarily associated with unsafe injection practices in patients in the United

States from 1998 through 2009. Of the 75,000 patients who were placed at risk,

620 became infected or died as a result of exposure. Events of unsafe syringe

reuse reported to the Pennsylvania Patient Safety Authority from 2004 through

2010 were associated with delivery of injectable medications during surgery,

vaccinations, and bedside care.

This article describes approaches to integrate safe injection strategies into

clinical practice and explains the key components of an infection prevention

program, including dispelling the misperceptions associated with unsafe

injection practices, increasing the awareness of safe injection practices, and

oversight of compliance with safe injection practices.

Reference: Prevent the Occurrence of Bloodborne Disease Transmission Associated

with Unsafe Injection Practices. Pa Patient Saf Advis 2011 Jun;8[2]:70-6.

[Guest guest]

http://www.infectioncontroltoday.com/news/2011/06/pa-patient-safety-authority-ex\

amines-unsafe-injection-practices.aspx

PA Patient Safety Authority Examines Unsafe Injection Practices

Posted in News, Bloodborne Pathogens, PPE & Standard Precautions, Sharps Safety,

Infections, Patient/Worker Safety, Patient Safety Print The June issue of the

Pennsylvania Patient Safety Authority Advisory includes a look at the occurrence

of bloodborne disease transmission related to unsafe injection practices.

Lapses in basic safe injection practices and infection control expose patients

to needless risk of transmission of bloodborne pathogens. The Centers for

Disease Control and Prevention and U.S. public health officials identified 51

reports of outbreaks of hepatitis B virus and hepatitis C virus infection

primarily associated with unsafe injection practices in patients in the United

States from 1998 through 2009. Of the 75,000 patients who were placed at risk,

620 became infected or died as a result of exposure. Events of unsafe syringe

reuse reported to the Pennsylvania Patient Safety Authority from 2004 through

2010 were associated with delivery of injectable medications during surgery,

vaccinations, and bedside care.

This article describes approaches to integrate safe injection strategies into

clinical practice and explains the key components of an infection prevention

program, including dispelling the misperceptions associated with unsafe

injection practices, increasing the awareness of safe injection practices, and

oversight of compliance with safe injection practices.

Reference: Prevent the Occurrence of Bloodborne Disease Transmission Associated

with Unsafe Injection Practices. Pa Patient Saf Advis 2011 Jun;8[2]:70-6.

[Guest guest]

http://www.infectioncontroltoday.com/news/2011/06/pa-patient-safety-authority-ex\

amines-unsafe-injection-practices.aspx

PA Patient Safety Authority Examines Unsafe Injection Practices

Posted in News, Bloodborne Pathogens, PPE & Standard Precautions, Sharps Safety,

Infections, Patient/Worker Safety, Patient Safety Print The June issue of the

Pennsylvania Patient Safety Authority Advisory includes a look at the occurrence

of bloodborne disease transmission related to unsafe injection practices.

Lapses in basic safe injection practices and infection control expose patients

to needless risk of transmission of bloodborne pathogens. The Centers for

Disease Control and Prevention and U.S. public health officials identified 51

reports of outbreaks of hepatitis B virus and hepatitis C virus infection

primarily associated with unsafe injection practices in patients in the United

States from 1998 through 2009. Of the 75,000 patients who were placed at risk,

620 became infected or died as a result of exposure. Events of unsafe syringe

reuse reported to the Pennsylvania Patient Safety Authority from 2004 through

2010 were associated with delivery of injectable medications during surgery,

vaccinations, and bedside care.

This article describes approaches to integrate safe injection strategies into

clinical practice and explains the key components of an infection prevention

program, including dispelling the misperceptions associated with unsafe

injection practices, increasing the awareness of safe injection practices, and

oversight of compliance with safe injection practices.

Reference: Prevent the Occurrence of Bloodborne Disease Transmission Associated

with Unsafe Injection Practices. Pa Patient Saf Advis 2011 Jun;8[2]:70-6.

[Guest guest]

http://www.infectioncontroltoday.com/news/2011/06/pa-patient-safety-authority-ex\

amines-unsafe-injection-practices.aspx

PA Patient Safety Authority Examines Unsafe Injection Practices

Posted in News, Bloodborne Pathogens, PPE & Standard Precautions, Sharps Safety,

Infections, Patient/Worker Safety, Patient Safety Print The June issue of the

Pennsylvania Patient Safety Authority Advisory includes a look at the occurrence

of bloodborne disease transmission related to unsafe injection practices.

Lapses in basic safe injection practices and infection control expose patients

to needless risk of transmission of bloodborne pathogens. The Centers for

Disease Control and Prevention and U.S. public health officials identified 51

reports of outbreaks of hepatitis B virus and hepatitis C virus infection

primarily associated with unsafe injection practices in patients in the United

States from 1998 through 2009. Of the 75,000 patients who were placed at risk,

620 became infected or died as a result of exposure. Events of unsafe syringe

reuse reported to the Pennsylvania Patient Safety Authority from 2004 through

2010 were associated with delivery of injectable medications during surgery,

vaccinations, and bedside care.

This article describes approaches to integrate safe injection strategies into

clinical practice and explains the key components of an infection prevention

program, including dispelling the misperceptions associated with unsafe

injection practices, increasing the awareness of safe injection practices, and

oversight of compliance with safe injection practices.

Reference: Prevent the Occurrence of Bloodborne Disease Transmission Associated

with Unsafe Injection Practices. Pa Patient Saf Advis 2011 Jun;8[2]:70-6.